Menon, Venu <br/><br/>
Impact of Baseline Glycemic Control on Residual Cardiovascular Risk in Patients With Diabetes Mellitus and High-Risk Vascular Disease Treated With Statin Therapy.  [electronic resource] 

 -  Journal of the American Heart Association  01 2020 
 - e014328 p.  digital 
<br/><br/> Publication Type: Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>2047-9980 
<br/><br/><label>Standard No.: </label>10.1161/JAHA.119.014328  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Aged<br/>Biomarkers--blood<br/>Blood Glucose--drug effects<br/>Cardiovascular Diseases--mortality<br/>Diabetes Mellitus, Type 2--blood<br/>Double-Blind Method<br/>Female<br/>Glycated Hemoglobin--metabolism<br/>Glycemic Control<br/>Heart Disease Risk Factors<br/>Humans<br/>Hydroxymethylglutaryl-CoA Reductase Inhibitors--therapeutic use<br/>Hypoglycemic Agents--therapeutic use<br/>Male<br/>Middle Aged<br/>Predictive Value of Tests<br/>Prospective Studies<br/>Risk Assessment<br/>Time Factors<br/>Treatment Outcome